9-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline is Approaching
17. November 2019 08:30 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Nov. 17, 2019 (GLOBE NEWSWIRE) -- Hagens Berman urges Myriad Genetics, Inc. (NASDAQ: MYGN) investors who have suffered losses in excess of $50,000 to submit their losses now or...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline is Approaching
12. November 2019 20:07 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Hagens Berman urges Myriad Genetics, Inc. (NASDAQ: MYGN) investors who have suffered losses in excess of $50,000 to submit their losses now or...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Myriad Genetics (MYGN) Investors of Securities Class Action, Encourages Investors Who Suffered Significant Losses to Contact the Firm
04. November 2019 20:01 ET
|
Hagens Berman Sobol Shapiro LLP
Class-action law firm urges MYGN investors who have suffered losses of $50K+ to submit your loss now to learn if they qualify to recover their investment losses. SAN FRANCISCO, Nov. 04, 2019 ...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, REMINDS MYGN INVESTORS OF CLASS ACTION: Myriad Genetics (MYGN) Investors Who Suffered Significant Losses are Encouraged to Contact the Firm
23. Oktober 2019 20:10 ET
|
Hagens Berman Sobol Shapiro LLP
Class-action law firm urges MYGN investors who have suffered losses of $50K+ to submit your loss now to learn if they qualify to recover their investment losses. SAN FRANCISCO, Oct. 23, 2019 (GLOBE...
MYGN SHAREHOLDER REMINDER: Hagens Berman Reminds Myriad Genetics (MYGN) Investors of Securities Fraud Lawsuit, Encourages Investors Who Lost $50,000+ to Contact the Firm
16. Oktober 2019 20:04 ET
|
Hagens Berman Sobol Shapiro LLP
Class-action law firm urges MYGN investors who have suffered losses of $50K+ to submit your loss now to learn if they qualify to recover their investment losses. SAN FRANCISCO, Oct. 16, 2019 (GLOBE...
MYGN CLASS ACTION REMINDER: Hagens Berman Reminds Myriad Genetics (MYGN) Investors of Securities Fraud Lawsuit, Encourages Investors Who Lost $50,000+ to Contact the Firm
07. Oktober 2019 19:48 ET
|
Hagens Berman Sobol Shapiro LLP
Class-action law firm urges MYGN investors who have suffered losses of $50,000+ to learn their shareholder rights SAN FRANCISCO, Oct. 07, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in...
MYGN CLASS ACTION REMINDER: Hagens Berman Reminds Investors in Myriad Genetics (MYGN) of Securities Fraud Lawsuit
01. Oktober 2019 20:04 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Myriad Genetics, Inc. (NASDAQ: MYGN) of the pending securities class action and urges MYGN investors who have...
MYGN INVESTIGATION REMINDER: Hagens Berman Reminds Myriad Genetics (MYGN) Investors of the Firm’s Ongoing Investigation of Possible Disclosure Violations
23. September 2019 20:02 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Myriad Genetics, Inc. (NASDAQ: MYGN) of the firm’s investigation of possible disclosure violations. RELEVANT...
MYGN Loss Alert: Hagens Berman Reminds Myriad Genetics (MYGN) Investors of Ongoing Investigation for Possible Disclosure Violations
17. September 2019 20:06 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Myriad Genetics, Inc. (NASDAQ: MYGN) of the firm’s investigation of possible disclosure violations. RELEVANT...
MYGN INVESTIGATION REMINDER: Hagens Berman Investigating Myriad Genetics (MYGN) For Possible Disclosure Violations
03. September 2019 20:12 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Myriad Genetics, Inc. (NASDAQ: MYGN) of the firm’s investigation of possible disclosure violations concerning its...